Table 2.

Organization and outcomes of national decision processes on rotavirus vaccine introduction in Scandinavian countries (Denmark, Finland, Norway, and Sweden).

	Rotavirus vaccine included in the national childhood vaccination program	NITAG established	National decision process on vaccine introduction
			Formal framework exists	Has cost-effectiveness (CE) analysis been applied	Results CE analysis, Societal perspective	Conclusion CE assessment health sector perspective	Main drivers for/against introduction
Denmark		+		+	Cost-effective when indirect costs included	Not cost-effective	Severity (mortality) criteria
Finland	+	+	+	+	“Reasonably” cost-effective	Not cost-effective	High morbidity burden, safe vaccines
Norway	+	+	+	+	Cost-effective when indirect costs included	Unlikely cost-effective	High morbidity burden
Sweden		+	+	+	Cost-effective and cost-saving when indirect costs included	Cost-effective but not cost-saving	High morbidity burden

NITAG, National Immunization Technical Advisory Groups.